Regional Prospective Observational Research in Tuberculosis (RePORT) India Consortium (RePORT-India)

报告印度是美国国立卫生研究院/艾滋病司（DAIDS）、国立卫生研究院/OAR和印度政府（GOI）印度生物技术部（DBT）以及印度医学研究委员会（ICMR）共同资助的一个项目，目的是在印美合作框架下在印度建立一个结核病队列联盟。疫苗行动计划（VAP）。联盟内的每个小组都有一个结核病患者的观察队列，以及他们与相关科学目标的联系，从生物标志物研究到了解这些人群中合并症的影响。这些研究工作的结果将显著影响并为合并感染结核病的艾滋病毒感染者的临床护理提供信息。每个报告联盟旨在支持国内数据收集、标本生物储存库和相关研究，目标是增加更多的区域联盟，以鼓励全球结核病（药物敏感和耐药）预防和治疗研究。

RePORT India is a jointly funded project between the U.S. NIH/Division of AIDS (DAIDS), NIH/OAR and the Government of India's (GOI) Indian Department of Biotechnology (DBT), and the Indian Council of Medical Research (ICMR) to establish a consortium of TB cohorts in India under the umbrella of the Indo-U.S. Vaccine Action Program (VAP). Each team within the consortia maintains an observational cohort(s) of TB patients and their contacts with associated scientific objectives ranging from biomarkers studies to understanding the impact of comorbidities in these populations. The results of such research efforts will significantly impact and inform the clinical care of people living with HIV (PLWH) with TB co-infection. Each RePORT consortium is designed to support in-country data collection, specimen biorepositories, and associated research with the goal of adding additional regional consortia to encourage worldwide TB (drug-susceptible and drug-resistant) prevention and treatment research.